Tokushima, Japan

Ayako Maita

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ayako Maita. Retrieved from https://idiyas.com/inventor/ayako-maita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ayako Maita: Innovator in Muscle Atrophy Research

Introduction

Ayako Maita is a prominent inventor based in Tokushima, Japan. She has made significant contributions to the field of biomedical research, particularly in the area of muscle atrophy. Her innovative work has led to the development of a unique composition aimed at suppressing muscular atrophy.

Latest Patents

Maita holds a patent for a composition designed to suppress muscular atrophy. This composition includes as active ingredients one or more peptides selected from a specific group, including tripeptides such as DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK. Additionally, it encompasses dipeptides comprising F and other dipeptides like DI, IY, YN, and NP. This patent highlights her commitment to advancing medical science and improving health outcomes.

Career Highlights

Ayako Maita is associated with Otsuka Pharmaceutical Company, Limited, where she continues her research and development efforts. Her work is characterized by a focus on innovative solutions to complex health issues, particularly those affecting muscle health.

Collaborations

Maita collaborates with esteemed colleagues, including Koichiro Hamada and Kiyohiko Magata. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the field of pharmaceutical innovation.

Conclusion

Ayako Maita's contributions to the field of muscle atrophy research exemplify her dedication to innovation and health improvement. Her patent and ongoing work at Otsuka Pharmaceutical Company, Limited, position her as a key figure in the advancement of biomedical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…